1 Market Overview

1.1 Product Overview and Scope of Cell-Free DNA (cf-DNA) Testing

1.2 Classification of Cell-Free DNA (cf-DNA) Testing by Type

1.2.1 Overview: Global Cell-Free DNA (cf-DNA) Testing Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Type in 2021

1.2.3 Donor-derived

1.2.4 Circulating

1.2.5 Cell-free

1.3 Global Cell-Free DNA (cf-DNA) Testing Market by Application

1.3.1 Overview: Global Cell-Free DNA (cf-DNA) Testing Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Oncology

1.3.3 Gynecology

1.3.4 Transplantation

1.4 Global Cell-Free DNA (cf-DNA) Testing Market Size & Forecast

1.5 Global Cell-Free DNA (cf-DNA) Testing Market Size and Forecast by Region

1.5.1 Global Cell-Free DNA (cf-DNA) Testing Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Cell-Free DNA (cf-DNA) Testing Market Size by Region, (2017-2022)

1.5.3 North America Cell-Free DNA (cf-DNA) Testing Market Size and Prospect (2017-2028)

1.5.4 Europe Cell-Free DNA (cf-DNA) Testing Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Market Size and Prospect (2017-2028)

1.5.6 South America Cell-Free DNA (cf-DNA) Testing Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Cell-Free DNA (cf-DNA) Testing Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Cell-Free DNA (cf-DNA) Testing Market Drivers

1.6.2 Cell-Free DNA (cf-DNA) Testing Market Restraints

1.6.3 Cell-Free DNA (cf-DNA) Testing Trends Analysis

2 Company Profiles

2.1 Agilent Technology

2.1.1 Agilent Technology Details

2.1.2 Agilent Technology Major Business

2.1.3 Agilent Technology Cell-Free DNA (cf-DNA) Testing Product and Solutions

2.1.4 Agilent Technology Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Agilent Technology Recent Developments and Future Plans

2.2 Allenex

2.2.1 Allenex Details

2.2.2 Allenex Major Business

2.2.3 Allenex Cell-Free DNA (cf-DNA) Testing Product and Solutions

2.2.4 Allenex Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Allenex Recent Developments and Future Plans

2.3 Biocept

2.3.1 Biocept Details

2.3.2 Biocept Major Business

2.3.3 Biocept Cell-Free DNA (cf-DNA) Testing Product and Solutions

2.3.4 Biocept Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Biocept Recent Developments and Future Plans

2.4 Biodesix

2.4.1 Biodesix Details

2.4.2 Biodesix Major Business

2.4.3 Biodesix Cell-Free DNA (cf-DNA) Testing Product and Solutions

2.4.4 Biodesix Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Biodesix Recent Developments and Future Plans

2.5 CareDx

2.5.1 CareDx Details

2.5.2 CareDx Major Business

2.5.3 CareDx Cell-Free DNA (cf-DNA) Testing Product and Solutions

2.5.4 CareDx Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 CareDx Recent Developments and Future Plans

2.6 Guardant Health

2.6.1 Guardant Health Details

2.6.2 Guardant Health Major Business

2.6.3 Guardant Health Cell-Free DNA (cf-DNA) Testing Product and Solutions

2.6.4 Guardant Health Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Guardant Health Recent Developments and Future Plans

2.7 Illumania

2.7.1 Illumania Details

2.7.2 Illumania Major Business

2.7.3 Illumania Cell-Free DNA (cf-DNA) Testing Product and Solutions

2.7.4 Illumania Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Illumania Recent Developments and Future Plans

2.8 Invited

2.8.1 Invited Details

2.8.2 Invited Major Business

2.8.3 Invited Cell-Free DNA (cf-DNA) Testing Product and Solutions

2.8.4 Invited Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Invited Recent Developments and Future Plans

2.9 Natera

2.9.1 Natera Details

2.9.2 Natera Major Business

2.9.3 Natera Cell-Free DNA (cf-DNA) Testing Product and Solutions

2.9.4 Natera Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Natera Recent Developments and Future Plans

2.10 Quest Diagnostics

2.10.1 Quest Diagnostics Details

2.10.2 Quest Diagnostics Major Business

2.10.3 Quest Diagnostics Cell-Free DNA (cf-DNA) Testing Product and Solutions

2.10.4 Quest Diagnostics Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Quest Diagnostics Recent Developments and Future Plans

2.11 Roche

2.11.1 Roche Details

2.11.2 Roche Major Business

2.11.3 Roche Cell-Free DNA (cf-DNA) Testing Product and Solutions

2.11.4 Roche Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Roche Recent Developments and Future Plans

2.12 Sequenom

2.12.1 Sequenom Details

2.12.2 Sequenom Major Business

2.12.3 Sequenom Cell-Free DNA (cf-DNA) Testing Product and Solutions

2.12.4 Sequenom Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Sequenom Recent Developments and Future Plans

2.13 Trovagene

2.13.1 Trovagene Details

2.13.2 Trovagene Major Business

2.13.3 Trovagene Cell-Free DNA (cf-DNA) Testing Product and Solutions

2.13.4 Trovagene Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Trovagene Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Cell-Free DNA (cf-DNA) Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Cell-Free DNA (cf-DNA) Testing Players Market Share in 2021

3.2.2 Top 10 Cell-Free DNA (cf-DNA) Testing Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Cell-Free DNA (cf-DNA) Testing Players Head Office, Products and Services Provided

3.4 Cell-Free DNA (cf-DNA) Testing Mergers & Acquisitions

3.5 Cell-Free DNA (cf-DNA) Testing New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Cell-Free DNA (cf-DNA) Testing Revenue and Market Share by Type (2017-2022)

4.2 Global Cell-Free DNA (cf-DNA) Testing Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Application (2017-2022)

5.2 Global Cell-Free DNA (cf-DNA) Testing Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Cell-Free DNA (cf-DNA) Testing Revenue by Type (2017-2028)

6.2 North America Cell-Free DNA (cf-DNA) Testing Revenue by Application (2017-2028)

6.3 North America Cell-Free DNA (cf-DNA) Testing Market Size by Country

6.3.1 North America Cell-Free DNA (cf-DNA) Testing Revenue by Country (2017-2028)

6.3.2 United States Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

6.3.3 Canada Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

6.3.4 Mexico Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Cell-Free DNA (cf-DNA) Testing Revenue by Type (2017-2028)

7.2 Europe Cell-Free DNA (cf-DNA) Testing Revenue by Application (2017-2028)

7.3 Europe Cell-Free DNA (cf-DNA) Testing Market Size by Country

7.3.1 Europe Cell-Free DNA (cf-DNA) Testing Revenue by Country (2017-2028)

7.3.2 Germany Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

7.3.3 France Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

7.3.5 Russia Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

7.3.6 Italy Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Revenue by Type (2017-2028)

8.2 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Revenue by Application (2017-2028)

8.3 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Market Size by Region

8.3.1 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Revenue by Region (2017-2028)

8.3.2 China Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

8.3.3 Japan Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

8.3.4 South Korea Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

8.3.5 India Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

8.3.7 Australia Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Cell-Free DNA (cf-DNA) Testing Revenue by Type (2017-2028)

9.2 South America Cell-Free DNA (cf-DNA) Testing Revenue by Application (2017-2028)

9.3 South America Cell-Free DNA (cf-DNA) Testing Market Size by Country

9.3.1 South America Cell-Free DNA (cf-DNA) Testing Revenue by Country (2017-2028)

9.3.2 Brazil Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

9.3.3 Argentina Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Revenue by Type (2017-2028)

10.2 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Revenue by Application (2017-2028)

10.3 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market Size by Country

10.3.1 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Revenue by Country (2017-2028)

10.3.2 Turkey Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

10.3.4 UAE Cell-Free DNA (cf-DNA) Testing Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Cell-Free DNA (cf-DNA) Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Cell-Free DNA (cf-DNA) Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Cell-Free DNA (cf-DNA) Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Cell-Free DNA (cf-DNA) Testing Revenue (USD Million) by Region (2017-2022)

Table 5. Global Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Region (2023-2028)

Table 6. Agilent Technology Corporate Information, Head Office, and Major Competitors

Table 7. Agilent Technology Major Business

Table 8. Agilent Technology Cell-Free DNA (cf-DNA) Testing Product and Solutions

Table 9. Agilent Technology Cell-Free DNA (cf-DNA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Allenex Corporate Information, Head Office, and Major Competitors

Table 11. Allenex Major Business

Table 12. Allenex Cell-Free DNA (cf-DNA) Testing Product and Solutions

Table 13. Allenex Cell-Free DNA (cf-DNA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Biocept Corporate Information, Head Office, and Major Competitors

Table 15. Biocept Major Business

Table 16. Biocept Cell-Free DNA (cf-DNA) Testing Product and Solutions

Table 17. Biocept Cell-Free DNA (cf-DNA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Biodesix Corporate Information, Head Office, and Major Competitors

Table 19. Biodesix Major Business

Table 20. Biodesix Cell-Free DNA (cf-DNA) Testing Product and Solutions

Table 21. Biodesix Cell-Free DNA (cf-DNA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. CareDx Corporate Information, Head Office, and Major Competitors

Table 23. CareDx Major Business

Table 24. CareDx Cell-Free DNA (cf-DNA) Testing Product and Solutions

Table 25. CareDx Cell-Free DNA (cf-DNA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Guardant Health Corporate Information, Head Office, and Major Competitors

Table 27. Guardant Health Major Business

Table 28. Guardant Health Cell-Free DNA (cf-DNA) Testing Product and Solutions

Table 29. Guardant Health Cell-Free DNA (cf-DNA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Illumania Corporate Information, Head Office, and Major Competitors

Table 31. Illumania Major Business

Table 32. Illumania Cell-Free DNA (cf-DNA) Testing Product and Solutions

Table 33. Illumania Cell-Free DNA (cf-DNA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Invited Corporate Information, Head Office, and Major Competitors

Table 35. Invited Major Business

Table 36. Invited Cell-Free DNA (cf-DNA) Testing Product and Solutions

Table 37. Invited Cell-Free DNA (cf-DNA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Natera Corporate Information, Head Office, and Major Competitors

Table 39. Natera Major Business

Table 40. Natera Cell-Free DNA (cf-DNA) Testing Product and Solutions

Table 41. Natera Cell-Free DNA (cf-DNA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Quest Diagnostics Corporate Information, Head Office, and Major Competitors

Table 43. Quest Diagnostics Major Business

Table 44. Quest Diagnostics Cell-Free DNA (cf-DNA) Testing Product and Solutions

Table 45. Quest Diagnostics Cell-Free DNA (cf-DNA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Roche Corporate Information, Head Office, and Major Competitors

Table 47. Roche Major Business

Table 48. Roche Cell-Free DNA (cf-DNA) Testing Product and Solutions

Table 49. Roche Cell-Free DNA (cf-DNA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Sequenom Corporate Information, Head Office, and Major Competitors

Table 51. Sequenom Major Business

Table 52. Sequenom Cell-Free DNA (cf-DNA) Testing Product and Solutions

Table 53. Sequenom Cell-Free DNA (cf-DNA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Trovagene Corporate Information, Head Office, and Major Competitors

Table 55. Trovagene Major Business

Table 56. Trovagene Cell-Free DNA (cf-DNA) Testing Product and Solutions

Table 57. Trovagene Cell-Free DNA (cf-DNA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Global Cell-Free DNA (cf-DNA) Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 59. Global Cell-Free DNA (cf-DNA) Testing Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 60. Breakdown of Cell-Free DNA (cf-DNA) Testing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Cell-Free DNA (cf-DNA) Testing Players Head Office, Products and Services Provided

Table 62. Cell-Free DNA (cf-DNA) Testing Mergers & Acquisitions in the Past Five Years

Table 63. Cell-Free DNA (cf-DNA) Testing New Entrants and Expansion Plans

Table 64. Global Cell-Free DNA (cf-DNA) Testing Revenue (USD Million) by Type (2017-2022)

Table 65. Global Cell-Free DNA (cf-DNA) Testing Revenue Share by Type (2017-2022)

Table 66. Global Cell-Free DNA (cf-DNA) Testing Revenue Forecast by Type (2023-2028)

Table 67. Global Cell-Free DNA (cf-DNA) Testing Revenue by Application (2017-2022)

Table 68. Global Cell-Free DNA (cf-DNA) Testing Revenue Forecast by Application (2023-2028)

Table 69. North America Cell-Free DNA (cf-DNA) Testing Revenue by Type (2017-2022) & (USD Million)

Table 70. North America Cell-Free DNA (cf-DNA) Testing Revenue by Type (2023-2028) & (USD Million)

Table 71. North America Cell-Free DNA (cf-DNA) Testing Revenue by Application (2017-2022) & (USD Million)

Table 72. North America Cell-Free DNA (cf-DNA) Testing Revenue by Application (2023-2028) & (USD Million)

Table 73. North America Cell-Free DNA (cf-DNA) Testing Revenue by Country (2017-2022) & (USD Million)

Table 74. North America Cell-Free DNA (cf-DNA) Testing Revenue by Country (2023-2028) & (USD Million)

Table 75. Europe Cell-Free DNA (cf-DNA) Testing Revenue by Type (2017-2022) & (USD Million)

Table 76. Europe Cell-Free DNA (cf-DNA) Testing Revenue by Type (2023-2028) & (USD Million)

Table 77. Europe Cell-Free DNA (cf-DNA) Testing Revenue by Application (2017-2022) & (USD Million)

Table 78. Europe Cell-Free DNA (cf-DNA) Testing Revenue by Application (2023-2028) & (USD Million)

Table 79. Europe Cell-Free DNA (cf-DNA) Testing Revenue by Country (2017-2022) & (USD Million)

Table 80. Europe Cell-Free DNA (cf-DNA) Testing Revenue by Country (2023-2028) & (USD Million)

Table 81. Asia-Pacific Cell-Free DNA (cf-DNA) Testing Revenue by Type (2017-2022) & (USD Million)

Table 82. Asia-Pacific Cell-Free DNA (cf-DNA) Testing Revenue by Type (2023-2028) & (USD Million)

Table 83. Asia-Pacific Cell-Free DNA (cf-DNA) Testing Revenue by Application (2017-2022) & (USD Million)

Table 84. Asia-Pacific Cell-Free DNA (cf-DNA) Testing Revenue by Application (2023-2028) & (USD Million)

Table 85. Asia-Pacific Cell-Free DNA (cf-DNA) Testing Revenue by Region (2017-2022) & (USD Million)

Table 86. Asia-Pacific Cell-Free DNA (cf-DNA) Testing Revenue by Region (2023-2028) & (USD Million)

Table 87. South America Cell-Free DNA (cf-DNA) Testing Revenue by Type (2017-2022) & (USD Million)

Table 88. South America Cell-Free DNA (cf-DNA) Testing Revenue by Type (2023-2028) & (USD Million)

Table 89. South America Cell-Free DNA (cf-DNA) Testing Revenue by Application (2017-2022) & (USD Million)

Table 90. South America Cell-Free DNA (cf-DNA) Testing Revenue by Application (2023-2028) & (USD Million)

Table 91. South America Cell-Free DNA (cf-DNA) Testing Revenue by Country (2017-2022) & (USD Million)

Table 92. South America Cell-Free DNA (cf-DNA) Testing Revenue by Country (2023-2028) & (USD Million)

Table 93. Middle East & Africa Cell-Free DNA (cf-DNA) Testing Revenue by Type (2017-2022) & (USD Million)

Table 94. Middle East & Africa Cell-Free DNA (cf-DNA) Testing Revenue by Type (2023-2028) & (USD Million)

Table 95. Middle East & Africa Cell-Free DNA (cf-DNA) Testing Revenue by Application (2017-2022) & (USD Million)

Table 96. Middle East & Africa Cell-Free DNA (cf-DNA) Testing Revenue by Application (2023-2028) & (USD Million)

Table 97. Middle East & Africa Cell-Free DNA (cf-DNA) Testing Revenue by Country (2017-2022) & (USD Million)

Table 98. Middle East & Africa Cell-Free DNA (cf-DNA) Testing Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Cell-Free DNA (cf-DNA) Testing Picture

Figure 2. Global Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Type in 2021

Figure 3. Donor-derived

Figure 4. Circulating

Figure 5. Cell-free

Figure 6. Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Application in 2021

Figure 7. Oncology Picture

Figure 8. Gynecology Picture

Figure 9. Transplantation Picture

Figure 10. Global Cell-Free DNA (cf-DNA) Testing Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Cell-Free DNA (cf-DNA) Testing Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Region (2017-2028)

Figure 13. Global Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Region in 2021

Figure 14. North America Cell-Free DNA (cf-DNA) Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Cell-Free DNA (cf-DNA) Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Cell-Free DNA (cf-DNA) Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Cell-Free DNA (cf-DNA) Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Cell-Free DNA (cf-DNA) Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Cell-Free DNA (cf-DNA) Testing Market Drivers

Figure 20. Cell-Free DNA (cf-DNA) Testing Market Restraints

Figure 21. Cell-Free DNA (cf-DNA) Testing Market Trends

Figure 22. Agilent Technology Recent Developments and Future Plans

Figure 23. Allenex Recent Developments and Future Plans

Figure 24. Biocept Recent Developments and Future Plans

Figure 25. Biodesix Recent Developments and Future Plans

Figure 26. CareDx Recent Developments and Future Plans

Figure 27. Guardant Health Recent Developments and Future Plans

Figure 28. Illumania Recent Developments and Future Plans

Figure 29. Invited Recent Developments and Future Plans

Figure 30. Natera Recent Developments and Future Plans

Figure 31. Quest Diagnostics Recent Developments and Future Plans

Figure 32. Roche Recent Developments and Future Plans

Figure 33. Sequenom Recent Developments and Future Plans

Figure 34. Trovagene Recent Developments and Future Plans

Figure 35. Global Cell-Free DNA (cf-DNA) Testing Revenue Share by Players in 2021

Figure 36. Cell-Free DNA (cf-DNA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 37. Global Top 3 Players Cell-Free DNA (cf-DNA) Testing Revenue Market Share in 2021

Figure 38. Global Top 10 Players Cell-Free DNA (cf-DNA) Testing Revenue Market Share in 2021

Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 40. Global Cell-Free DNA (cf-DNA) Testing Revenue Share by Type in 2021

Figure 41. Global Cell-Free DNA (cf-DNA) Testing Market Share Forecast by Type (2023-2028)

Figure 42. Global Cell-Free DNA (cf-DNA) Testing Revenue Share by Application in 2021

Figure 43. Global Cell-Free DNA (cf-DNA) Testing Market Share Forecast by Application (2023-2028)

Figure 44. North America Cell-Free DNA (cf-DNA) Testing Sales Market Share by Type (2017-2028)

Figure 45. North America Cell-Free DNA (cf-DNA) Testing Sales Market Share by Application (2017-2028)

Figure 46. North America Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Country (2017-2028)

Figure 47. United States Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Canada Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Mexico Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Europe Cell-Free DNA (cf-DNA) Testing Sales Market Share by Type (2017-2028)

Figure 51. Europe Cell-Free DNA (cf-DNA) Testing Sales Market Share by Application (2017-2028)

Figure 52. Europe Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Country (2017-2028)

Figure 53. Germany Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. France Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. United Kingdom Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Russia Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Italy Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Asia-Pacific Cell-Free DNA (cf-DNA) Testing Sales Market Share by Type (2017-2028)

Figure 59. Asia-Pacific Cell-Free DNA (cf-DNA) Testing Sales Market Share by Application (2017-2028)

Figure 60. Asia-Pacific Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Region (2017-2028)

Figure 61. China Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Japan Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South Korea Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. India Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Southeast Asia Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Australia Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. South America Cell-Free DNA (cf-DNA) Testing Sales Market Share by Type (2017-2028)

Figure 68. South America Cell-Free DNA (cf-DNA) Testing Sales Market Share by Application (2017-2028)

Figure 69. South America Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Country (2017-2028)

Figure 70. Brazil Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Argentina Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Middle East and Africa Cell-Free DNA (cf-DNA) Testing Sales Market Share by Type (2017-2028)

Figure 73. Middle East and Africa Cell-Free DNA (cf-DNA) Testing Sales Market Share by Application (2017-2028)

Figure 74. Middle East and Africa Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Country (2017-2028)

Figure 75. Turkey Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Saudi Arabia Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. UAE Cell-Free DNA (cf-DNA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Methodology

Figure 79. Research Process and Data Source